.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Covington
Julphar
Argus Health
Harvard Business School
Healthtrust
Farmers Insurance
Cantor Fitzgerald
Teva
UBS

Generated: September 19, 2017

Patent: ► Subscribe

Summary for Patent: ► Subscribe

Title:Compositions including triciribine and methods of use thereof
Abstract: This invention encompasses combination therapies including TCN, TCN-P, TCN-PM and/or related compounds and one or more additional anti-cancer agents, for example, taxanes a molecule that modulates the HER2/neu (erbB2) receptor, anthracyclin compounds, epidermal growth factor receptor inhibitor compounds, one or more platinum compounds and bortezomib and derivatives thereof and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.
Inventor(s): Cheng; Jin Q. (Tampa, FL), Sebti; Said M. (Tampa, FL)
Assignee: University of Florida (Tampa, FL)
Application Number:14/514,311
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Genentech
HERCEPTIN
trastuzumab
VIAL; INTRAVENOUS1037920011998-09-25► Subscribe University of Florida (Tampa, FL) Cheng; Jin Q. (Tampa, FL), Sebti; Said M. (Tampa, FL) ► SubscribeRXOrphansearch
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: ► Subscribe

Country Document Number Publication Date
Australia2005228410Oct 13, 2005
Canada2561513Oct 13, 2005
Canada2724246Nov 19, 2009
China1984663Jun 20, 2007
Denmark2574341Jun 26, 2017
European Patent Office1737472Aug 13, 2014
European Patent Office1737472Jan 03, 2007
European Patent Office1737472Sep 01, 2010
European Patent Office2300055Mar 30, 2011
European Patent Office2574341Apr 03, 2013
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Harvard Business School
Queensland Health
Healthtrust
Teva
Cantor Fitzgerald
Boehringer Ingelheim
Moodys
Fuji
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot